Profil
Fred Kurland formerly worked at Applied Immune Sciences, Inc., as Chief Financial Officer & Vice President from 1995 to 1996, Protein Design Labs, Inc., as Chief Financial Officer & Vice President from 1996 to 1998, Syntex Corp., as Vice President & Controller from 1991 to 1995, MedImmune Vaccines, Inc., as Chief Financial Officer & Senior Vice President from 1998 to 2002, XOMA Corp., as Chief Financial Officer, Secretary & VP from 2013 to 2015, Corcept Therapeutics, Inc., as Chief Financial Officer from 2004 to 2007, Genitope Corp., as Chief Financial Officer & Vice President from 2002 to 2004, Bayhill Therapeutics, Inc., as Chief Financial Officer, Aridis Pharmaceuticals, Inc., as Chief Financial & Accounting Officer, and Aridis Pharmaceuticals, Inc., as Chief Financial Officer from 2015 to 2019.
Mr. Kurland received his graduate degree and Masters Business Admin degree from The University of Chicago and undergraduate degree from Lehigh University.
Ehemalige bekannte Positionen von Fred Kurland
| Unternehmen | Position | Ende |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 04.08.2023 |
| ARIDIS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 31.12.2019 |
| XOMA ROYALTY CORPORATION | Finanzdirektor/CFO | 03.04.2015 |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Finanzdirektor/CFO | - |
| CORCEPT THERAPEUTICS INCORPORATED | Finanzdirektor/CFO | 13.04.2007 |
Ausbildung von Fred Kurland
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Surgical & medical instruments | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Corcept Therapeutics, Inc.
Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Genitope Corp.
Genitope Corp. BiotechnologyHealth Technology Develops immunotherapies for the treatment of cancer | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for infectious diseases | Health Technology |
















